« Previous
Next »
Titles
- AMX0035 and oral edaravone for amyotrophic lateral sclerosis: final evidence report1
- Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pre-treated relapsed and refractory multiple myeloma: final report1
- Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report1
- Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report1
- Medications for obesity management: effectiveness and value : final evidence report1
- Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects: revised evidence report1
- Special assessment of outpatient treatments for COVID-19: final evidence report and meeting summary1
- Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update1
- Tirzepatide for type 2 diabetes: final report1